Respiratory system

Toxicologic Pathology: Nonclinical Safety Assessment

Volumn , Issue , 2013, Pages 367-420

  Lewis, David J ^a   McKevitt, Tom P ^a  

^a GLAXOSMITHKLINE   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 84988721372     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1201/b13783     Document Type: Chapter

References (350)

1. Abrams, W.R., Cohen, A.B., Damiano, V.V., Eliraz, A., Kimbel, P., Meranze, D.R., and Weinbaum, G., 1981. A model of decreased functional α-1-proteinase inhibitor. J Clin Invest 68:1132-1139.
2. Allen, J.E., and Rasmussen, H., 1971. Human red blood cells: Prostaglandin E2, epinephrine, and isoproterenol alter deformability. Science 174:512-514.
3. Amouzadeh, H.R., Sangiah, S., Qualls Jr., C.W., Cowell, R.L., and Mauromoustakos, A., 1991. Xylazine-induced pulmonary edema in rats. Toxicol Appl Pharmacol 108:417-427.
4. Anderson, N., and Borlak, J., 2006. Drug-induced phospholipidosis. FEBS Letters 580:5533-5540.
5. Andrews, C.M., and Papworth, S., 1994. Rat haemoglobin crystallisation. Comp Haematol Int 4:244.
6. Araya, J., Cambier, S., Markovics, J.A., Wolters, P., Jablons, D., Hill, A., Finkbeiner, W., Jones, K., Broaddus, V.C., Sheppard, D., Barzcak, A., Xiao, Y., Erle, D.J., and Nishimura, S.L., 2007. Squamous metaplasia amplifies pathologic epithelial-mesenchymal interactions in COPD patients. J Clin Invest 117:3551-3562.
7. Aryal, G., Kimula, Y., and Koike, M., 2003. Ultrastructure of Clara cells stimulated by isoproterenol. J Med Dent Sci 50:195-202.
8. Aydoğan, S., Yerer, M.B., Çomu, F.M., Arslan, M., Güneş-Ekinci, I., Unal, Y., and Kurtipek, O., 2006. The influence of sevoflurane anesthesia on rat red blood cell deformability. Clin Haemorheol Microcirc 35:297-300.
9. Baldwin, R.M., Jewell, W.T., Fanucchi, M.V., Plopper, C.G., and Buckpitt, A.R., 2004. Comparison of pulmonary/nasal CYP2F expression levels in rodents and rhesus macaque. J Pharmacol Exp Ther 309:127-136.
10. Balis, J.U., Paterson, J.F., Haller, E.M., Shelley, S.A., and Montgomery, M.R., 1988. Ozone-induced lamellar body responses in a rat model for alveolar injury and repair. Am J Pathol 132:330-344.
11. Barton, E.G., and Campbell, W.G., 1969. Pneumocystis carinii in lungs of rats treated with cortisone acetate. Am J Pathol 54(2):209-236.
12. Batenburg, J.J., and Haagsman, H.P., 1998. The lipids of pulmonary surfactant: Dynamics and interactions with proteins. Prog Lipid Res 37(4):235-276.
13. Bauer, A.K., Malkinson, A.M., and Kleeberger, S.R., 2004. Susceptibility to neoplastic and non-neoplastic pulmonary diseases in mice: genetic similarities. Am J Physiol Lung Cell Molec Physiol 287:L685-L703.
14. Beckmann, N., Tigani, B., Mazzoni, L., and Fozard, J.R., 2003. Techniques: magnetic resonance imaging of the lung provides potential for non-invasive preclinical evaluation of drugs. Trends Pharmacol Sci 24:550-554.
15. Beneke, S., and Rooney, S.A., 2001. Glucocorticoids regulate expression of the fatty acid synthase gene in fetal rat type II cells. Biochim Biophys Acta 1534:56-63.
16. Bennett, J.V., de Castro, J.F., Valdespino-Gomez, J.L., Garcia-Garcia, M., Islas-Romero, R., Echaniz-Aviles, G., Jimenez-Corona, A., and Sepulveda-Amor, J., 2002. Aerosolized measles and measles-rubella vaccines induce better measles antibody booster responses than injected vaccines: randomized trials in Mexican schoolchildren. Bull World Health Organ 80:806-812.
17. Bergman, U.B., Östergren, A., Gustafson, A.-L.G., and Brittebo, E.B., 2002. Differential effects of olfactory toxicants on olfactory regeneration. Arch Toxicol 76:104-112.
18. Bernick, S., and Alfin-Slater, R.B., 1963. Pulmonary infiltration of lipid in essential fatty-acid deficiency. Progressive changes. Arch Pathol 75:13-20.
19. Berry, C.R., Ackerman, N., and Monce, K., 1994. Pulmonary mineralization in four dogs with Cushing’s syndrome. Vet Radiol Ultrasound 35(1):10-16.
20. Bhattacharyya, N., 2002. Cancer of the nasal cavity: survival and factors influencing prognosis. Arch Otolaryngol Head Neck Surg 128:1079-1083.
21. Bitterman, P.B., Saltzman, L.E., Adelberg, S., Ferrans, V.J., and Crystal, R.G., 1984. Alveolar macrophage replication. One mechanism for the expansion of the mononuclear phagocyte population in the chronically inflamed lung. J Clin Invest 74:460-469.
22. Blank, F., Rothen-Rutishauser, B., and Gehr, P., 2007. Dendritic cells and macrophages form a transepithelial network against foreign particulate antigens. Am J Respir Cell Mol Biol 36:669-677.
23. Blois, S.L., Caron. I., and Mitchell, C., 2009. Diagnosis and outcome of a dog with iatrogenic hyperadrenocorticism and secondary pulmonary mineralization. Can Vet J 50:397-400.
24. Bolton, S.J., Pinnion, K., Oreffo, V., Foster, M., and Pinkerton, K.E., 2009. Characterisation of the proximal airway squamous metaplasia induced by chronic tobacco smoke exposure in spontaneously hypertensive rats. Resp Res 10:118.
25. Boorman, G.A., Morgan, K.T., and Uraih, L.C., 1990. Nose, larynx and trachea. In Pathology of the Fischer Rat. G. Boorman, S.L. Eustis, C. Montgomery, and M. Elwell, editors. Academic Press, San Diego, pp. 315-338.
26. Boorman, G., Dixon, D., Elwell, M., Kerlin, R., Morton, D., Peters, T., Regan, K., and Sullivan, J., 2003. Assessment of hyperplastic lesions in rodent carcinogenicity studies. Toxicol Pathol 31:709-710.
27. Born, S.L., Fix, A.S., Caudill, D., and Lehman-McKeeman, L.D., 1998. Selective Clara cell injury in mouse lung following acute administration of coumarin. Toxicol Appl Pharmacol 151:45-56.
28. Bowdridge, S., and Gause, W.C., 2010. Regulation of alternative macrophage activation by chromatin remodeling. Nat Immunol 11:879-881.
29. Bozza, P.T., Magalhães, K.G., and Weller, P.F., 2009. Leukocyte lipid bodies-biogenesis and functions in inflammation. Biochim Biophys Acta 1791:540-551.
30. Brix, A.E., Latimer, K.S., Moore, G.E., and Roberts, R.E., 1994. Pulmonary alveolar microlithiasis and ossification in a dog. Vet Pathol 31:382-385.
31. Brown, H.R., Monticello, T.M., Maronpot, R.R., Randall, H.W., Hotchkiss, J.R., and Morgan, K.T., 1991. Proliferative and neoplastic lesions in the rodent nasal cavity. Toxicol Pathol 19:358-372.
32. Brown, D.M., Dransfield, I., Wetherill, G.Z., and Donaldson, K., 1993. LFA-1 and ICAM-1 in homotypic aggregation of rat alveolar macrophages: organic dust-mediated aggregation by a non-protein kinase C-dependent pathway. Am J Respir Cell Mol Biol 9:205-212.
33. Bucher, J.R., Huff, J., Haseman, J.K., Eustis, S.L., and Elwell, M.R., 1990a. Toxicology and carcinogenicity studies of diuretics in F344 rats and B6C3F1 mice 1. Hydrochlorothiazide. J Appl Toxicol 10(5):359-367.
34. Bucher, J.R., Huff, J., Haseman, J.K., Eustis, S.L., and Elwell, M.R., 1990b. Toxicology and carcinogenicity studies of diuretics in F344 rats and B6C3F1 mice 1. Furosemide. J Appl Toxicol 10(5):369-378.
35. Buckley, L.A., Morgan, K.T., Swenberg, J.A., James, R.A., Hamm, T.E., and Barrow, C.S., 1985. The toxicity of dimethylamine in F-344 rats and B6C3F1 mice following a 1-year inhalation exposure. Fundam Appl Toxicol 5:341-352.
36. Burns, M.G., Kelly, A.B., Hornoff, W.J., and Howerth, E.W., 1981. Pulmonary artery thrombosis in three dogs with hyperadrenocorticism. J Am Vet Mod Assoc 178:388-393.
37. Byers, D.E., and Holtzman, M.J., 2010. Alternatively activated macrophages as cause or effect in airway disease. Am J Respir Cell Mol Biol 43:1-4.
38. Calderwood, H.W., Modell, J.H., Rogow, L., Tham, M.K., and Hood, I., 1973. Morphologic and biochemical changes in dogs after ventilation with caroxin-D fluorocarbon. Anesthesiology 39(5):488-495.
39. Capen, C.C., Belshaw, B.E., and Martin, S.L., 1975. Endocrine disorders. In: Textbook of Veterinary Internal Medicine. S.J. Ettinger, editor. Sanders, Philadelphia, PA, pp. 1395-1403.
40. Casarosa, P., Bouyssou, T., Germeyer, S., Schnapp, A., Gantner, F., and Pieper, M., 2009. Preclinical evaluation of long-acting muscarinic antagonists: comparison of tiotropium and investigational drugs. J Pharmacol Exp Therapeutics 330:660-668.
41. Cesta, M.F., 2006. Normal structure, function, and histology of mucosa-associated lymphoid tissue. Toxicol Pathol 34:599-608.
42. Chan, E.D., Morales, D.V., Welsh, C.H., McDermott, M.T., and Schwarz, M.I., 2002. Calcium deposition with or without bone formation in the lung. Am J Respir Crit Care Med 165:1654-1669.
43. Chan, H.-K., and Gonda, I., 1989. Aerodynamic properties of elongated particles of cromoglycic acid. J Aerosol Sci 20(2):157-168.
44. Chandler, F.W., Frenkel, J.K., and Campbell, W.G., 1979. Animal model: Pneumocystis carinii pneumonia in the immunosuppressed rat. Am J Pathol 95(2):571-574.
45. Chandra, M., and Frith, C.H., 1992. Spontaneous neoplasms in B6C3F1 mice. Toxicol Lett 60:91-98.
46. Chang, J.C., Jagirdas, J., and Lesser, M., 1986. Long-term evolution of BCG-and CFA-induced granulomas in rat lungs. Correlation of histologic features with cells in bronchoalveolar lavage samples. Am J Pathol 125(1):16-27.
47. Chang, S.-W., and Ohara, N., 1994. Chronic biliary obstruction induces pulmonary intravascular phagocytosis and endotoxin sensitivity in rats. J Clin Invest 94:2009-2019.
48. Chiba, T., Bharucha, A.E., Thomforde, G.M., Kost, L.J., and Phillips, S.F., 2002. Model of rapid gastrointestinal transit in dogs: effects of muscarinic antagonists as a nitric oxide synthase inhibitor. Neurogastroenterol Motil 14(5):535-541.
49. Chono, S., Tanino, T., Seki, T., and Morimoto, K., 2006. Influence of particle size on drug delivery to rat alveolar macrophages following pulmonary administration of ciprofloxacin incorporated into liposomes. J Drug Target 14(8):557-566.
50. Chono, S., Tanino, T., Seki, T., and Morimoto, K., 2008. Efficient drug delivery to alveolar macrophages and lung epithelial lining fluid following pulmonary administration of liposomal ciprofloxacin in rats with pneumonia and estimation of its antibacterial effects. Drug Dev Ind Pharm 34:1090-1096.
51. Christmann, U., Buechner-Mxwell, V.A., Witonsky, S.G., and Hite, R.D., 2009. Role of lung surfactant in respiratory disease: current knowledge in large animal medicine. J Vet Intern Med 23:227-242.
52. Christopher, M.M., White, J.G., and Eaton, J.W., 1990. Erythrocyte pathology and mechanisms of Heinz body-mediated hemolysis in cats. Vet Pathol 27:299-310.
53. Clarke, J., Hurst, C., Martin, P., Vahle, J., Ponce, R., Mounho, B., Heidel, S., Andrews, L., Reynolds, T., and Cavagnaro, J., 2008. Duration of chronic toxicity studies for biotechnology-derived pharmaceuticals: is 6 months still appropriate? Regulat Toxicol Pharmacol 50:2-22.
54. Contrera, J.F., Jacobs, A.C., and DeGeorge, J.J., 1997. Carcinogenicity testing and the evaluation of regulatory requirements for pharmaceuticals. Regulat Toxicol Pharmacol 25:130-145.
55. Coonrod, J.D., Lester, R.L., and Hsu, L.C., 1984. Characterisation of the extracellular bactericidal factors of rat alveolar lining material. J Clin Invest 74(4):1269-1279.
56. Costa, R.H., Kalinichenko, V.V., and Lim, L., 2001. Transcription factors in mouse lung development and function. Am J Physiol Lung Cell Mol Physiol 280:L823-L838.
57. Cottrell, T.S., Levine, O.R., Senior, R.M., Wiener, J., Spiro, D., and Fishman, A.P., 1967. Electron microscopic alterations at the alveolar level in pulmonary edema. Circ Res XXI(6):783-797.
58. Crowell, W.A., Finco, D.R., Rawlings, C.A., Barsanti, J.A., and Rao, R.N., 1978. Lesions in dogs following renal transplantation and immunosuppression. Vet Pathol 24(2):124-128.
59. Cui, B., Cheng, Y.-S., Dai, D.-Z., Li, N., Zhang, T.-T., and Dai, Y., 2009. CPU0213, A non-selective ETA/ETB receptor antagonist, improves pulmonary arteriolar remodelling of monocrotaline-induced pulmonary hypertension in rats. Clin Exp Pharmacol Physiol 36:169-175.
60. Curran, D.R., and Cohn, L., 2010. Advances in mucous cell metaplasia: a plug for mucus as a therapeutic focus in chronic airway disease. Am J Respir Cell Mol Biol 42:268-275.
61. Damsch, S., Eichenbaum, G., Tonelli, A., Lammens, L., Van Den Bulck, K., Feyen, B., Vandenberghe, J., Megens, A., Knight, E., and Kelley, M., 2011. Gavage-related reflux in rats: identification, pathogenesis, and toxicological implications (review). Toxicol Pathol 39:348-360.
62. Davies, N.M., and Feddah, M.R., 2003. A novel method for assessing dissolution of aerosol inhaler products. Int J Pharmaceut 255:175-187.
63. Davis, C.W., and Dickey, B.F., 2008. Regulated airway goblet cell mucin secretion. Annu Rev Physiol 70:487-512.
64. Davis, M.S., Schofield, B., and Freed, A.N., 2003. Repeated peripheral airway hyperpnea causes inflammation and remodeling in dogs. Med Sci Sports Exerc 35(4):608-616.
65. Dayan, A.D., Morgan, R.J., Trefty, B.T., and Paddock, T.B., 1978. Naturally occurring diatomaceous pneumoconiosis in sub-human primates. J Comp Pathol 88(2):321-325.
66. Dayer, A.M., Kapanci, Y., Rademakers, A., Rusy, L.M., De Mey, J., and Will, J.A., 1985. Increased numbers of neuroepithelial bodies (NEB) in lungs of fetal rhesus monkeys following maternal dexamethasone treatment. Cell Tissue Res 239:703-705.
67. Degryse, A.L., and Lawson, W.E., 2011. Progress toward improving animal models for idiopathic pulmonary fibrosis. Am J Med Sci 341(6):444-449.
68. Delaunois, L.M., 2004. Mechanisms in pulmonary toxicology. Clin Chest Med 25:1-14.
69. DeLorme, M.P., and Moss, O.R., 2001. Pulmonary function assessment by whole-body plethysmography in restrained versus unrestrained mice. J Pharmacol Toxicol Methods 47:1-10.
70. Dixon, D., and Maronpot, R.R., 1991. Histomorphologic features of spontaneous and chemically-induced pulmonary neoplasms in B6C3F1 mice and Fischer 344 rats. Toxicol Pathol 19:540-555.
71. Dobbs, L.G., Johnson, M.D., Vanderbilt, J., Allen, L., and Gonzalez, R., 2010. The great big alveolar TI cell: evolving concepts and paradigms. Cell Physiol Biochem 25:55-62.
72. Driehuys, B., and Hedlund, L.W., 2007. Imaging techniques for small animal models of pulmonary disease: MR microscopy. Toxicol Pathol 35:49-58.
73. Duan, J.D., Jeffrey, A.M., and Williams, G.M., 2008. Assessment of the medicines lidocaine, prilocaine, and their metabolites, 2,6-dimethylaniline and 2-methylaniline, for DNA adduct formation in rat tissues. Drug Metab Dispos 36:1470-1475.
74. Dudley, R.E., Patterson, S.E., Machotka, S.V., and Kesterson, J.W., 1989. One-month inhalation toxicity study of tulobuterol hydrochloride in rats and dogs. Fundam Appl Toxicol 13:694-701.
75. Duffield, J.S., 2003. The inflammatory macrophage: a story of Jekyll and Hyde. Clin Sci 104:27-38.
76. Dungworth, D.L., Ernst, H., Nolte, T., and Mohr, U., 1992. Nonneoplastic lesions in the lungs. In: Pathobiology of the Aging Rat. U. Mohr, D.L. Dungworth, and C.C. Capen, editors. ILSI Press, Washington, DC, pp. 141-160.
77. Dungworth, D.L., Rittinghausen, S., Schwartz, L., Harkema, J.R., Hayashi, Y., Kittel, B., Lewis, D., Miller, R.A., Mohr, U., Morgan, K.T., Rehm, S., and Slayter, M.V., 2001. Respiratory system and mesothelium. In: International Classification of Rodent Tumors, The Mouse. U. Mohr, editor. Springer, London, pp. 87-138.
78. Duong, M., Ouellet, N., Simard, M., Bergeron, Y., Olivier, M., and Bergeron, M.G., 1998. Kinetic study of host defense and inflammatory response to Aspergillus fumigatus in steroid-induced immunosuppressed mice. J Infect Dis 178:1472-1482.
79. Dvorak, A.M., Morgan, E., Schleimer, R.P., Ryeom S.W., Lichtenstein, L.M., and Weller, P.F., 1992. Ultrastructural immunogold localization of prostaglandin endoperoxide synthase (cyclooxygenase) to non-membrane-bound cytoplasmic lipid bodies in human lung mast cells, alveolar macrophages, type II pneumocytes, and neutrophils. J Histochem Cytochem 40:759-769.
80. Edelson, J.D., Shannon, J.M., and Mason, R.J., 1988. Alkaline phosphatase: a marker of alveolar type II cell differentiation. Am Rev Respir Dis 138:1268-1275.
81. Eichenbaum, G., Damsch, S., Looszova, A., Vandenberghe, J., Van den Bulck, K., Roels, K., Megens, A., Knight, E., Hillsamer, V., Feyen, B., Kelley, M.F., Tonelli, A., and Lammens, L., 2011. Impact of gavage dosing procedure and gastric content on adverse respiratory effects and mortality in rat toxicity studies. J Appl Toxicol 31:342-354.
82. Endo, M., Oyadomari, S., Terasaki, Y., Takeya, M., Suga, M., Mori, M., and Gotoh, T., 2003. Induction of arginase I and II in bleomycin-induced fibrosis of mouse lung. Am J Physiol Lung Cell Mol Physiol 285:L313-L321.
83. Etherton, J.E., Conning, D.M., and Corrin, B., 1973. Autoradiographical and morphological evidence for apocrine secretion of dipalmitoyl lecithin in the terminal bronchiole of mouse lung. Am J Anat 138:11-36.
84. Eustis, S.L., 1989. The sequential development of cancer: A morphological perspective. Toxicol Lett 49:267-281.
85. Evans, M.J., Cabral, L.J., Stephens, R.J., and Freeman, G., 1975. Transformation of alveolar type 2 cells to type 1 cells following exposure to NO2. Exp Molec Pathol 22:142-150.
86. Ewing, P., Ryrfeldt, A., Sjöberg, C.-O., Andersson, P., Edsbäcker, S., and Gerde, P., 2010. Vasoconstriction after inhalation of budesonide: A study in the isolated and perfused rat lung. Pulm Pharmacol Therapeut 23:9-14.
87. Fallon, M.B., 2005. Mechanisms of pulmonary vascular complications of liver disease. Hepatopulmonary syndrome. J Clin Gastroenterol 39:S138-S142.
88. Fanucchi, M.V., and Plopper, C.G., 1997. Pulmonary developmental responses to toxicants. In: Comprehensive Toxicology. I.G. Sipes, C.A. McQueen, and A.J. Gandolfi, editors. Pergamon Elsevier Science, New York, pp. 203-220.
89. Farbman, A.I., 1990. Olfactory neurogenesis: genetic or environmental controls? Trends Neurosci 13:362-365.
90. Fehrenbach, A., Bube, C., Hohlfeld, J.M., Stevens, P.A., Tschernig, T., Hoymann, H.G., Krug, N., and Fehrenbach, H., 2003. Surfactant homeostasis is maintained in vivo during KGF-induced rat lung type II cell hyperplasia. Am J Respir Crit Care Med 167(9):1264-1270.
91. Fehrenbach, H., Kasper, M., Tschernig, T., Pan, T., Schuh, D., Shannon, J.M., Müller, M., and Mason, R.J., 1999. Keratinocyte growth factor-induced hyperplasia of rat alveolar type II cells in vivo is resolved by differentiation into type I cells and by apoptosis. Eur Respir J 14:534-544.
92. Fehrenbach, H., Fehrenbach, A., Pan, T., Kasper, M., and Mason, R.J., 2002. Keratinocyte growth factor-induced proliferation of rat airway epithelium is restricted to Clara cells in vivo. Eur Respir J 20:1185-1197.
93. Fengming, L., Zengli, W., Xiaojing, L., Chuntao, L., Xiaohong, Z., and Wenzhi, W., 2002. The effect of budesonide on Clara cell secretory protein and its mRNA expression in a rat model of asthma. Chin J Tuberculosis Respir Dis 25(9):538-541.
94. Ferin, J., 1982. Alveolar macrophage mediated pulmonary clearance suppressed by drug-induced phospholipidosis. Exp Lung Res 4:1-10.
95. Flodh, H., and Magnusson, G., 1973. Genesis of foam cells: study in rats after administration of Intralipid®. Acta Pathol Microbiol Scand 81(5):651-656.
96. Floettmann, E., Gregory, L., Teague, J., Myatt, J., Hammond, C., Poucher, S.M., and Jones, H.B., 2010. Prolonged inhibition of glycogen phosphorylase in livers of Zucker diabetic fatty rats models human glycogen storage disease. Toxicol Pathol 38:393-401.
97. Forbes, B., Asgharian, B., Dailey, L.A., Ferguson, D., Gerde, P., Gumbleton. M., Gustavsson, L., Hardy, C., Hassall, D., Jones, R., Lock, R., Maas. J., McGovern, T., Pitcairn, G.R., Somers, G., and Wolff, R.K., 2011. Challenges in inhaled product development and opportunities for open innovation. Adv Drug Del Rev 63:69-87.
98. Foster, D.J., Ravikumar, P., Bellotto, D.J., Unger, R.H., and Hsia, C.C.W., 2010. Fatty diabetic lung: altered alveolar structure and surfactant protein expression. Am J Physiol Lung Cell Mol Physiol 298:L392-L403.
99. Fringes, B., Gorgas, K., and Reith, A., 1988a. Modification of surfactant metabolizing cells in rat lung by clofibrate, a hypolipidemic peroxisome proliferating agent. Evidence to suggest that clofibrate influences pulmonary surfactant metabolism. Virchows Archiv B Cell Pathol 54:232-240.
100. Fringes, B., Gorgas, K., and Reith, A., 1988b. Clofibrate increases the number of peroxisomes and of lamellar bodies in alveolar cells type II of the rat lung. Eur J Cell Biol 46(1):136-143.
101. Fringes, B., Gorgas, K., and Reith, A., 1988c. Two hypolipidemic peroxisome proliferators increase the number of lamellar bodies in alveolar cells type II of the lung. Exp Mol Pathol 48(2):262-271.
102. Fults, K.A., Miller, I.F., and Hickey, A.J., 1997. Effect of particle morphology on emitted dose of fatty acid-treated disodium cromoglycate powder aerosols. Pharm Dev Technol 2(1):67-79.
103. Gehr, P., Green, F.H.Y., Geiser, M., Hof, I.M., Lee, M.M., and Schürch, S., 1996. Airway surfactant, a primary defense barrier: mechanical and immunological aspects. J Aerosol Med 9(2):164-181.
104. Geiser, M., 2010. Update on macrophage clearance of inhaled micro-and nanoparticles. J Aerosol Med Pulm Drug Deliv 23(4):207-217.
105. Genta, R.M., and Schad, G.A., 1984. Filaroides hirthi: hyperinfective lungworm infection in immunosuppressed dogs. Vet Pathol 21:349-354.
106. Genter, M.B., Deamer, N.J., Blake, B.L., Wesley, D.S., and Levi, P.E., 1995. Olfactory toxicity of methimazole: dose-response and structure-activity studies and characterization of flavin-containing monooxygenase activity in the Long-Evans rat olfactory mucosa. Toxicol Pathol 23:477-486.
107. Genter, M.B., Liang, H.C., Gu, J., Ding, X., Negishi, M., McKinnon, R.A., and Nebert, D.W., 1998. Role of CYP2A5 and 2G1 in acetaminophen metabolism and toxicity in the olfactory mucosa of the Cyp1a2(-/-) mouse. Biochem Pharmacol 55:1819-1826.
108. Germann, P.G., Ockert, D., and Tuch, K. 1995. Oropharyngeal granulomas and tracheal cartilage degeneration in Fischer-344 rats. Toxicol Pathol 23:349-355.
109. Germann, P.G., Ockert, D., and Heinrichs, M., 1998. Pathology of the oropharyngeal cavity in six strains of rats: predisposition of Fischer 344 rats for inflammatory and degenerative changes. Toxicol Pathol 26:283-289.
110. Gibson, G., and Barrett, E., 1992. The role of salivary function on oropharyngeal colonization. Spec Care Dentist 12(4):153-156.
111. Gil, J., and Weibel, E.R., 1971. Extracellular lining of bronchioles after perfusion-fixation of rat lungs for electron microscopy. Anat Rec 169(2):185-199.
112. Goggs, R., Benigni, L., Fuentes, V.L., and Chan, D.L., 2009. Pulmonary thromboembolism. J Vet Emerg Crit Care 19(1):30-52.
113. Gopinath, C., Prentice, D.E., and Lewis, D.J., 1987. The respiratory system. In: Atlas of Experimental Toxicological Pathology. MTP Press, Lancaster, pp. 22-42.
114. Gorbunov, N.V., Asher, L.V., Ayyagari, V., and Atkins, J.L., 2006. Inflammatory leukocytes and iron turnover in experimental hemorrhagic lung trauma. Exp Mol Pathol 80:11-25.
115. Gordon, S., 2003. Alternative activation of macrophages. Nat Rev Immunol 3:23-35.
116. Goya, S., Matsuoka, H., Mori, M., Morishita, H., Kida, H., Kobashi, Y., Kato, T., Taguchi, Y., Osaki, T., Tachibana, I., Nishimoto, N., Yoshizaki, K., Kaware, I., and Hayashi, S., 2003. Sustained interleukin-6 signalling leads to the development of lymphoid organ-like structures in the lung. J Pathol 200(1):82-87.
117. Greaves, P., 2007. Histopathology of Preclinical Toxicity Studies, 3rd edition, Elsevier, Amsterdam, pp. 215-269.
118. Greaves, P., and Faccini, J.M., 1984. Rat Histopathology, Elsevier, Amsterdam, pp. 62-73.
119. Grebenskaya, N.I., 1966. Histochemistry of lipids in the lungs. Bull Exp Biol Med 64(3):1019-1021.
120. Gross, E.A., Patterson, D.L., and Morgan, K.T., 1987. Effects of acute and chronic dimethylamine exposure on the nasal mucociliary apparatus of F-344 rats. Toxicol Appl Pharmacol 90:359-376.
121. Gross, P., Pfitzer, E.A., and Hatch, T.F., 1966. Alveolar clearance: its relation to lesions of the respiratory bronchiole. Am Rev Resp Dis 94:10-19.
122. Gu, J., Walker, V.E., Lipinskas, T.W., Walker, D.M., and Ding, X., 1997. Intraperitoneal administration of coumarin causes tissue-selective depletion of cytochromes P450 and cytotoxicity in the olfactory mucosa. Toxicol Appl Pharmacol 146:134-143.
123. Guidot, D.M., Modelska, K., Lois, M., Jain, L., Moss, I.M., Pittet, J-F., and Brown, L.A.S., 2000. Ethanol ingestion via glutathione depletion impairs alveolar epithelial barrier function in rats. Am J Physiol Lung Cell Mol Physiol 279:L127-L135.
124. Hagen, G., Wolf, M., Katyal, S.L., Singh, G., Beato, M., and Suske, G., 1990. Tissue specific expression, hormonal regulation at 51-flanking gene region of the rat Clara cell 10KDa protein comparison with rabbit uteroglobin. Nucleic Acids Res 18:2939-2946.
125. Hahn, F.F., Muggenburg, B.A., and Griffith, W.C., 1996. Primary lung neoplasia in a beagle colony. Vet Pathol Online 33:633-638.
126. Hahn, F.F., Gigliotti, A., and Hutt, J.A., 2007. Comparative oncology of lung tumors. Toxicol Pathol 35:130-135.
127. Hahn, F.F., and Dagle, G.E., 2001. Non-neoplastic pulmonary lesions. In: Pathobiology of the Aging Dog. U. Mohr, W.W. Carlton, D.L. Dungworth, S.A. Benjamin, C.C. Capen, and F.F. Hahn, editors. Iowa State University Press, Ames, IA, pp. 57-65.
128. Haley, P.J., 2003. Species differences in the structure and function of the immune system. Toxicology 188:49-71.
129. Hallman, M., and Bry, K., 1996. Nitric oxide and lung surfactant. Semin Perinatol 20(3):173-185.
130. Hammer, A.S., 1991. Thrombocytosis in dogs and cats: a retrospective study. Comp Haematol Int 1:181-186.
131. Hanton, G., Sobry, C., Dagues, J.P., Provost, J.P., Le Net, J.-L., Comby, P., and Chevalier, S., 2008. Characterisation of the vascular and inflammatory lesions induced by the PDE4 inhibitor CI-1044 in the dog. Toxicol Lett 179:15-22.
132. Hanumegowda, U.M., Wenke, G., Regueiro-Ren, A., Yordanova, R., Corradi, J.P., and Adams, S.P., 2010. Phospholipidosis as a function of basicity, lipophilicity, and volume of distribution of compounds. Chem Res Toxicol 23:749-755.
133. Hardisty, J.F., Garman, R.H., Harkema, J.R., Lomax, L.G., and Morgan, K.T., 1999. Histopathology of nasal olfactory mucosa from selected inhalation toxicity studies conducted with volatile chemicals. Toxicol Pathol 27:618-627.
134. Harkema, J.R., 1990. Comparative pathology of the nasal mucosa in laboratory animals exposed to inhaled irritants. Environ Health Perspect 85:231-238.
135. Harkema, J.R., 1991. Comparative aspects of nasal airway anatomy: relevance to inhalation toxicology. Toxicol Pathol 19:321-336.
136. Harkema, J.R., Carey, S.A., and Wagner, J.G., 2006. The nose revisited: a brief review of the comparative structure, function, and toxicologic pathology of the nasal epithelium. Toxicol Pathol 34:252-269.
137. Harmsen, A.G., Mason, M.J., Muggenburg, B.A., Gillett, N.A., Jarpe, M.A., and Bice, D.E., 1987. Migration of neutrophils from lung to tracheobronchial lymph node. J Leuk Biol 41(2):95-103.
138. Hartings, J.M., and Roy, C.J., 2001. The automated bioaerosol exposure system: preclinical platform development and a respiratory dosimetry application with nonhuman primates. J Pharmacol Toxicol Methods 49:39-55.
139. Haseman, J.K., and Hailey, J.R., 1997. An update of the National Toxicology Program database on nasal carcinogens. Mutat Res/Fundam Molec Mech Mutagen 380:3-11.
140. Haseman, J.K., Arnold, J., and Eustis, S.L., 1990. Tumor incidences in Fischer 344 rats: NTP historical data. In: Pathology of the Fischer Rat. G. Boorman, S.L. Eustis, C. Montgomery, and M. Elwell, editors. Academic Press, San Diego, pp. 555-564.
141. Haseman, J.K., Hailey, J.R., and Morris, R.W., 1998. Spontaneous neoplasm incidences in Fischer 344 rats and B6C3F1 mice in two-year carcinogenicity studies: a National Toxicology Program update. Toxicol Pathol 26:428-441.
142. Haworth, R., Woodfine, J., McCawley, S., Pilling, A.M., Lewis, D.J., and Williams, T.C., 2007. Pulmonary neuroendocrine cell hyperplasia: identification, diagnostic criteria and incidence in untreated ageing rats of different strains. Toxicol Pathol 35:735-740.
143. Hayashi, H., Kumazaki, T., and Asano, G., 1994. Pulmonary edema induced by intravenous administration of contact media: experimental study in rats. Radiat Med 12(2):47-52.
144. Heidsiek, J.G., Hyde, D.M., Plopper, C.G., and St George, J.A., 1987. Quantitative histochemistry of mucosubstance in tracheal epithelium of the macaque monkey. J Histochem Cytochem 35:435-442.
145. Helming, L., and Gordon, S., 2009. Molecular mediators of macrophage fusion. Trends Cell Biol 19(10):514-522.
146. Henderson, R.F., 2005. Use of bronchoalveolar lavage to detect respiratory tract toxicity of inhaled material. Exp Toxicol Pathol 57:155-159.
147. Henderson, R.F., Driscoll, K.E., Harkema, J.R., Lindenschmidt, R.C., Chang, I.-Y., Maples, K.R., and Barr, E.B., 1995. A comparison of the inflammatory response of the lung to inhaled versus instilled particles in F344 rats. Fundam Appl Toxicol 24:183-197.
148. Herbert, R.A., and Leininger, J.R., 1999. Nose, larynx and trachea. In: Pathology of the Mouse. R.R. Maronpot, editor. Cache River Press, Vienna, IL, pp. 259-292.
149. Hermans, C., and Bernard, A., 1999. Lung epithelium-specific proteins. Characteristics and potential applications as markers. Am J Respir Crit Care Med 159:646-678.
150. Hermans, C., Knoops, B., Wiedig, M., Arsalane, K., Toubeau, G., Falmagne, P., and Bernard, A., 1999. Clara cell protein as a marker of Clara cell damage and bronchoalveolar blood barrier permeability. Eur Respir J 13:1014-1021.
151. Hilbe, M., Sydler, T., Fischer, L., and Naegeli, H., 2000. Metastatic calcification in a dog attributable to ingestion of a tacalcitol ointment. Vet Pathol 37:490-492.
152. Hilloowala, R.A., and Lass, N.J., 1978. Spectrographic analysis of laryngeal air sac resonance in rhesus monkey. Am J Phys Anthropol 49:129-131.
153. Hoenerhoff, M.J., Starost, M.F., and Ward, J.M., 2006. Eosinophilic crystalline pneumonia as a major cause of death in 129S4/SvJae mice. Vet Pathol 43:682-688.
154. Hohlfeld, J., Fabel, H., and Hamm, H., 1997. The role of pulmonary surfactant in obstructive airways disease. Eur Respir J 10:482-491.
155. Holt, P.F., 1983. Translocation of inhaled dust to the pleura. Environ Res 31:212-220.
156. Hood, C.I., and Modell, J.H., 2000. A morphologic study of long-term retention of fluorocarbon after liquid ventilation. Chest 118:1436-1440.
157. Hook, G.E.R., 1991. Alveolar proteinosis and phopholipidoses of the lungs. Toxicol Pathol 19:482-513.
158. Howroyd, P., Allison, N., Foley, J.F., and Hardisty, J., 2009. Apparent alveolar bronchiolar tumors arising in the mediastinum of F344 rats. Toxicol Pathol 37:351-358.
159. Hoymann, H.G., 2006. New developments in lung function measurements in rodents. Exp Toxicol Pathol 57:5-11.
160. Hoyt, J., 1990. Analytic reviews: aspiration pneumonitis: patient risk factors, prevention and management. J Int Care Med 5:S2-S9.
161. Hyde, D.M., Harkema, J.R., Tyler, N.K., and Plopper, C.G., 2006. Design-based sampling and quantitation of the respiratory airways. Toxicol Pathol 34:286-295.
162. Innes, J.R.M., Garner, F.M., and Stookey, J.L., 1967, Respiratory disease in rats. In: Pathology of Laboratory Rats and Mice. E. Cotchin and F.J.C. Roe, editors. Blackwell Scientific Publications, Oxford and Edinburgh, pp. 229-257.
163. Isaka, H., Yoshi, H., Otsuji, A., Koike, M., Nagai, Y., Masatoshi, K., Sugiyasu, K., and Kanabayashi, T., 1979. Tumors of Sprague-Dawley rats induced by long-term feeding of phenacetin. Gann 70:29-36.
164. Jeffrey, A.M., Iatropoulos, M.J., and Williams, G.M., 2006. Nasal cytotoxic and carcinogenic activities of systemically distributed organic chemicals. Toxicol Pathol 34:827-852.
165. Jeffery, P.K., and Reid, L., 1975. New observations of rat airway epithelium: a quantitative and electron microscopic study. J. Anat 120:295-320.
166. Johanson, G., 2003. Occupational exposure limits-approaches and criteria. Proc NIVA Uppsala, Sweden, 24-28 September 2001. Arbete och Halsa 17:1-109.
167. Johnson, K.A., 2007. Imaging techniques for small animal imaging models of pulmonary disease: micro-CT. Toxicol Pathol 35:59-64.
168. Kambara, T., McKevitt, T.P., Francis, I., Woodfine, J.A., McCawley, S.J., Jones, S.A., Pilling, A.M., Lewis, D.J., and Williams, T.C., 2009. Eosinophilic inclusions in rat Clara cells and the effect of an inhaled corticosteroid. Toxicol Pathol 37:315-323.
169. Karnati, S., and Baumgart-Vogt, E., 2008. Peroxisomes in mouse and human lung: their involvement in pulmonary lipid metabolism. Histochem Cell Biol 130(4):719-740.
170. Kasahara, Y., Tuder, R.M., Taraseviciene-Stewart, L., Le Cras, T.D., Abman, S., Hirth, P.K., Waltenberger, J., and Voelkel, N.F., 2000. Inhibition of VEGF receptors causes lung cell apoptosis and emphysema. J Clin Invest 106:1311-1319.
171. Kasahara, K., Yamakawa, S., Nagatani, M., Tsurukame, M., and Tamura, K., 2008. Spontaneous leiomyosarcoma arising from the ethmoid turbinate of a rat. Toxicol Pathol 36:247-249.
172. Kaspareit, J., Friderichs-Gromoll, S., Buse, E., and Habermann, G., 2007. Spontaneous neoplasms observed in cynomolgus monkeys (Macaca fascicularis) during a 15-year period. Exp Toxicol Pathol 59:163-169.
173. Kaufmann, W., Bader, R., Ernst, H., Harada, T., Hardisty, J., Kittel, B., Kolling, A., Pino, M., Renne, R., Rittinghausen, S., Schulte, A., Wöhrmann, T., and Rosenbruch, M., 2009. 1st International ESTP Expert Workshop: “Larynx squamous metaplasia.” A re-consideration of morphology and diagnostic approaches in rodent studies and its relevance for human risk assessment. Exp Toxicol Pathol 61:591-603.
174. Kehrer, J.P., and Kacew, S., 1985. Systematically applied chemicals that damage lung tissue. Toxicology 35:251-293.
175. Kennedy, M.A., Barrera, G.C., Nakamura, K., Baldan, A., Tarr, P., Fishbein, M.C., Frank, J., Francone, O.L., and Edwards, P.A., 2005. ABCG1 has a critical role in mediating cholesterol efflux to HDL and preventing cellular lipid accumulation. Cell Metab 1:121-131.
176. Kepler, G.M., Joyner, D.R., Fleishman, A., Richardson, R., Gross, E.A., Morgan, K.T., Kimbell, J.S., and Godo, M.N., 1995. Method for obtaining accurate geometrical coordinates of nasal airways for computer dosimetry modeling and lesion mapping. Inhal Toxicol 7:1207-1224.
177. Khoor, A., Gray, M.E., Singh, G., and Stahlman, M.T., 1996. Ontogeny of Clara cell-specific protein and its mRNA: their association with neuroepithelial bodies in human fetal lung and in bronchopulmonary dysplasia. J Histochem Cytochem 44:1429-1438.
178. Kikkawa, Y., and Suzuki, K., 1972. Alteration of cellular and acellular alveolar and bronchiolar walls produced by hypocholesteremic drug AY99. Lab Invest 26(4):441-447.
179. Kishore, U., Greenhough, T.J., Waters, P., Shrive, A.K., Ghai, R., Kamran, M.F., Bernal, A.L., Reid, K.B.M., Madan, T., and Chakraborty, T., 2006. Surfactant proteins SP-A and SP-D: structure, function and receptors. Mol Immunol 43:1293-1315.
180. Kitamura, H., Inayama, Y., Ito, T., Yabana, M., Piegorsch, W.W. and Kanisawa, M., 1987. Morphologic alteration of mouse Clara cells induced by glycerol: ultrastructural and morphometric studies. Exp Lung Res 12:281-302.
181. Kittel, B., Ruehl-Fehlert, C., Morawietz, G., Klapwijk, J., Elwell, M.R., Lenz, B., O’Sullivan, M.G., Roth, D.R., and Wadsworth, P.F., 2004. Revised guides for organ sampling and trimming in rats and mice-Part 2: A joint publication of the RITA and NACAD groups. Exp Toxicol Pathol 55:413-431.
182. Klapwijk, J., 2011. HESI Emerging Issues. Alveolar macrophage changes in response to inhaled drugs: factors distinguishing adaptive from adverse effects. HESI Annual Meeting, June 2011.
183. Kleinig, T.J., Helps, S.C., Ghabriel, M.N., Manavis, J., Leigh, C., Blumbergs, P.C., and Vink, R., 2009. Hemoglobin crystals: A pro-inflammatory potential confounder of rat experimental intracerebral haemorrhage. Brain Res 1287:164-172.
184. Kooistra, H.S., and Galac, S., 2010. Recent advances in the diagnosis of Cushing’s syndrome in dogs. Vet Clin Small Anim 40:259-267.
185. Koyama, S., Sato, E., Nomura, H., Kubo, K., Nagai, S., and Izumi, T., 1997. Type II pneumocytes release chemoattractant activity for monocytes constitutively. Am J Physiol 272:L830-L837.
186. Kramer, B.W., Jobe, A.H., and Ikegami, M., 2001. Exogenous surfactant changes the phenotype of alveolar macrophages in mice. Am J Physiol Lung Cell Mol Physiol 280:L689-L694.
187. Kreyling, W.G., Takenaka, S., Schumann, G., and Ziesenis, A., 2001. Particles are predominantly transported from the canine alveolar epithelium towards the interstitial spaces and not to larynx! Analogy to human lungs. Am J Respir Crit Care Med 163:A166.
188. Kuempel, E.D., 2000. Comparison of human and rodent lung dosimetry models for particle clearance and retention. Drug Chem Toxicol 23(1):203-222.
189. Kumar, V., Abbas, A., Fausto, N., and Aster, J., 2010. Acute and chronic inflammation. In: Pathologic Basis of Disease. V. Kumar, A. Abbas, N. Fausto, and J. Aster, editors. Saunders Elsevier, Philadelphia, pp. 43-78.
190. Lanken, P.N., Minda, M., Pietra, G.G., and Fishman, A.P., 1980. Alveolar responses to experimental Pneumocystis carinii pneumonia in the rat. Am J Pathol 99:561-588.
191. Laplante, C., and Lemaire, I., 1990. Interactions between alveolar macrophage subpopulations modulate their migratory function. Am J Pathol 136:199-206.
192. Larsen, A.K., Newberne, P.M., and Langer, R., 1986. Comparative studies of heparin and heparin fragments: distribution and toxicity in the rat. Fundam Appl Toxicol 7:86-93.
193. Laskin, D.L., Sunil, V.R., Gardner, C.R., and Laskin, J.D., 2011. Macrophages and tissue injury: agents of defense or destruction? Annu Rev Pharmacol Toxicol 51:267-288.
194. Lehnert, B.E., 1990. Alveolar macrophages in a particle “overload” condition. J Aerosol Med 3(1):S9-S30.
195. Lehnert, B.E., 1992. Pulmonary and thoracic macrophage subpopulations and clearance of particles from the lung. Environ Health Perspect 97:17-46.
196. Leininger, J.R., Herbert, R.A., and Morgan, K.T., 1996. Aging changes in the upper respiratory tract. In: Pathobiology of the Aging Mouse, Volume 1. U. Mohr, D.L. Dungworth, C.C. Capen, W.W. Carlton, J.P. Sundberg, and J.M. Ward, editors. ILSI, Washington, pp. 245-328.
197. Lewis, D.J., 1981. Factors affecting the distribution of tobacco smoke-induced lesions in the rodent larynx. Toxicol Lett 9:189-194.
198. Lewis, D.J., 1991. Morphological assessment of pathological changes within the rat larynx. Toxicol Pathol 19:352-357.
199. Lewis, J.L., Nikula, K.J., and Sachetti, L.A., 1995. Induced xenobiotic metabolizing enzymes localized to eosinophilic globules in olfactory epithelium of toxicant-exposed F344 rats. In: Nasal Toxicity and Dosimetry of Inhaled Xenobiotics: Implications for Human Health. F.J. Miller, editor. Taylor & Francis, Washington, DC, pp. 422-425.
200. Li, X., Botts, S., Morton, D., Knickerbocker, M.J., and Adler, R., 2006. Oleic acid-associated bronchiolitis obliterans-organizing pneumonia in beagle dogs. Vet Pathol 43:183-185.
201. Liebow, A.A., 1959. Pulmonary emphysema with reference to vascular changes. Am Rev Respir Dis 80(1):67-93.
202. Livingston, R.S., Besch-Williford, C.L., Myles, M.H., Franklin, C.L., Crim, M.J., and Riley, L.K., 2011. Pneumocystis carinii infection causes lung lesions historically attributed to rat respiratory virus. Comp Med 61(1):45-52.
203. Lopez, I., Aguilera-Tejero, E., Mendoza, F.J., Almaden, Y., Perez, J., Martin, D., and Rodriguez M., 2006. Calcimimetic R-568 decrease extraosseous calcifications in uremic rats treated with calcitriol. J Am Soc Nephrol 17:795-804.
204. Losco, P.E., Evans, E.W., Barat, S.A., Blackshear, P.E., Reyderman, L., Fine, J.S., Bober, L.A., Anthes, J.C., Mirro, E.J., and Cuss, F.M., 2004. The toxicity of SCH 351591, a novel phosphodiesterase-4 inhibitor in cynomolgus monkeys. Toxicol Pathol 32(3):295-308.
205. Ma, J., Chen, T., Mandelin, J., Ceponis, A., Miller, N.E., Hukkanen, M., Ma, G.F., and Konttinen, Y.T., 2003. Regulation of macrophage activation. CMLS Cell Mol Life Sci 60:2334-2346.
206. Macklin, C.C., 1955. Pulmonary sumps, dust accumulations, alveolar fluid and lymph vessels. Acta Anat 23:1-33.
207. Maita, K., Hirano, M., Harada, T., Mitsumori, K., Yoshida, A., Takahashi, K., Nakashima, N., Kitazawa, T., Enomoto, A., Inui, K., and Shirasu, Y., 1988. Mortality, major cause of moribundity, and spontaneous tumors in CD-1 mice. Toxicol Pathol 16:340-349.
208. Massaro, G.D., Fischman, C.M., Chiang, M.J., Amado, C., and Massaro, D., 1981. Regulation of secretion in Clara cells: studies using the isolated perfused rat lung. J Clin Invest 67:345-351.
209. Mendes, E.S., Pereira, A., Danta, I., Duncan, R.C., and Wanner, A., 2003. Comparative bronchial vasoconstrictive efficacy of inhaled glucocorticosteroids. Eur Respir J 21:989-993.
210. Mery, S., Gross, E.A., Joyner, D.R., Godo, M., and Morgan, K.T., 1994. Nasal diagrams: a tool for recording the distribution of nasal lesions in rats and mice. Toxicol Pathol 22:353-372.
211. Meyrick, B., 2001. The pathology of pulmonary artery hypertension. Clin Chest Med 22(3):393-404.
212. Michael, B., Yano, B., Sellers, R.S., Perry, R., Morton, D., Roome, N., Johnson, J.K., and Schafer, K., 2007. Evaluation of organ weights for rodent and non-rodent toxicity studies: a review of regulatory guidelines and a survey of current practices. Toxicol Pathol 35:742-750.
213. Miot-Noirault, E., Faure, L., Guichard, Y., Montharu, J., and Le Pape, A., 2001. Scintigraphic in vivo assessment of the development of pulmonary intravascular macrophages in liver disease. Experimental study in rats with biliary cirrhosis. Chest 120:941-947.
214. Miserocchi, G., 2007. Lung interstitial pressure and structure in acute hypoxia. Hypoxia and the Circulation. R.C. Roach et al., editors. Springer, New York, pp. 141-168.
215. Misson, P., van den Brule, S., Barbarin, V., Lison, D., and Huaux, F., 2004. Markers of macrophage differentiation in experimental silicosis. J Leukoc Biol 76:926-932.
216. Modell, J.H., Calderwood, H.W., Ruiz, B.C., Tham, M.K., and Hood, C.I., 1976. Liquid ventilation of primates. Chest 69:79-81.
217. Monticello, T.M., Morgan, K.T., and Uraih, L., 1990. Nonneoplastic nasal lesions in rats and mice. Environ Health Perspect 85:249-274.
218. Morrow, P.E., 1972. Lymphatic drainage of the lung in dust clearance. NY Acad Sci 22:46-65.
219. Morrow, P.E., 1988. Possible mechanisms to explain dust overloading of the lungs. Fundam Appl Toxicol 10:369-384.
220. Morrow, P.E., 1992. Dust overloading of the lungs: update and appraisal. Toxicol Appl Pharmacol 113:1-12.
221. Mosser, D.M., and Edwards, J.P., 2008. Exploring the full spectrum of macrophage activation. Nat Rev Immunol 8(12):958-969.
222. Murphy, D.J. 1994. Safety pharmacology of the respiratory system: techniques and study design. Drug Dev Res 32:237-246.
223. Murphy, D.J., Renninger, J.P., and Coatney, R.W., 2007. A novel method for chronic measurement of respiratory function in the conscious monkey. J Pharmacol Toxicol Methods 46:13-20.
224. Murray, P.J., and Wynn, T.A., 2011. Obstacles and opportunities for understanding macrophage polarization. J Leukoc Biol 89:557-563.
225. Myers, M.A., Thomas, D.A., Straub, L., Soucy, D.W., Niven, R.W., Kaltenbach, M., Hood, C.I., Schreier, H., and Gonzalez-Rothi, R.J., 1993. Pulmonary effects of chronic exposure to liposome aerosols in mice. Exp Lung Res 19:1-19.
226. Myers, R.B., Fredenburgh, J.L., and Grizzle, W.E., 2008. Carbohydrates. In: Theory and Practice of Histological Techniques. J.D. Bancroft and M. Gamble, editors. Churchill Livingstone Elsevier, Philadelphia, pp. 161-186.
227. Nalesnik, M.A., Todo, S., Murase, N., Gryzan, S., Lee, P.-H., Makowka, L., and Starzl, T.E., 1987. Toxicology of FK-506 in the Lewis rat. Transplant Proc 19(5 Supp 6):89-92.
228. Namovic, M.T., Walsh, R.E., Goodfellow, C., Harris, R.R., Carter, G.W., and Bell, R.L., 1996. Pharmacological modulation of eosinophil influx into the lungs of Brown Norway rats. Eur J Pharmacol 315:81-88.
229. Nelson, A.A., and Fitzhugh, O.G., 1948. Chloroquine (SN-7618) pathologic changes observed in rats which for 2 years had been fed various proportions. Arch Pathol 45(4):454-462.
230. Nemes, Z., Dietz, R., Mann, J.F.E., Luth, J.B., and Gross, F., 1980. Vasoconstriction and increased blood pressure in the development of accelerated vascular disease. Virchows Arch A Pathol Anat Histol 386:161-173.
231. Nettesheim, P., and Szakal, A.K., 1972. Morphogenesis of alveolar bronchiolization. Lab Invest 26(2):210-219.
232. Nielsen, S., King, L.S., Christensen, B.M., and Agre, P., 1997. Aquaporins in complex tissues. II. Subcellular distribution in respiratory and glandular tissues of rat. Am J Physiol Cell Physiol 273:C1549-C1561.
233. Nikitin, A.Y., Alcaraz, A., Anver, M.R., Bronson, R.T., Cardiff, R.D., Dixon, D., Fraire, A.E., Gabrielson, E.W., Gunning, W.T., Haines, D.C., Kaufman, M.H., Linnoila, R.I., Maronpot, R.R., Rabson, A.S., Reddick, R.L., Rehm, S., Rozengurt, N., Schuller, H.M., Shmidt, E.N., Travis, W.D., Ward, J.M., and Jacks, T., 2004. Classification of proliferative pulmonary lesions of the mouse. Cancer Res 64:2307-2316.
234. Nkadi, P.O., Merritt, T.A., and Pillers, D.-E.M., 2009. An overview of pulmonary surfactant in the neonate: genetics, metabolism, and the role of surfactant in health and disease. Mol Genet Metab 97:95-101.
235. Noorman, F., Braat, E.A., Barrett-Bergshoeff, M., Barbe, E., van Leeuwen, A., Lindeman, J., and Rijken, D.C., 1997. Monoclonal antibodies against the human mannose receptor as a specific marker in flow cytometry and immunohistochemistry for macrophages. J Leukoc Biol 61:63-72.
236. Nunes, H., Lebrec, D., Mazmanian, M., Capron, F., Heller, J., Tazi, K.A., Zerbib, E., Dulmet, E., Moreau, R., Dinh-Xuan, A.T., Simonneau, G., and Hervé, P., 2001. Role of nitric oxide in hepatopulmonary syndrome in cirrhotic rats. Am J Respir Crit Care Med 164:879-885.
237. Obert, L.A., Sobocinski, G.P., Bobrowski, W.F., Metz, A.L., Rolsma, M.D., Altrogge, D.M., and Dunstan, R.W., 2007. An immunohistochemical approach to differentiate hepatic lipidosis from hepatic phospholipidosis in rats. Toxicol Pathol 35:728-734.
238. Ochs, M., Nenadic, I., Fehrenbach, A., Albes, J.M., Wahlers, T., Richter, J., and Fehrenbach, H., 1999. Ultrastructural alterations in intraalveolar surfactant subtypes after experimental ischemia and reperfusion. Am J Respir Crit Care Med 160:718-724.
239. Ochs, M., Fehrenbach, H., and Richter, J., 2004. Occurrence of lipid bodies in canine type II pneumocytes during hypothermic lung ischemia. Anat Rec Part A 277a:287-297.
240. OECD, 2009. OECD Environment Directorate Publications Series on Testing and Assessment No. 39-Guidance Document on Acute Inhalation Toxicity Testing.
241. Ohmiya, Y., Angevine, L.S., and Mehendale, H.M., 1983. Effect of drug induced phospholipidosis on pulmonary disposition of pneumophilic drugs. Drug Metab Dispos 11:25-30.
242. Okazaki, S., Yamazaki, E., Tamura, K., Hoshiya, T., Anabuki, K., Tanaka, H., and Tanaka, G., 1992. A 13-week subcutaneous toxicity study of prednisolone farnesylate (PNF) in rats. J Toxicol Sci 17(III):1-48.
243. Okigami, H., Takeshita, K., Tajimi, M., Komura, H., Albers, M., Lehmann, T.E., Rölle, T., and Bacon, K.B., 2007. Inhibition of eosinophilia in vivo by a small molecule inhibitor of very late antigen (VLA)-4. Eur J Pharmacol 559:202-209.
244. Oliveira, M.J.R., Pereira, A.S., Guimarães, L., Grande, N.R., Moreira de Sá, C., and Aquas, A.P., 2003. Zonation of ciliated cells on the epithelium of the rat trachea. Lung 181:275-282.
245. Owen, K., 2011. Regulatory toxicology considerations for the development of inhaled pharmaceuticals. Drug Chem Toxicol. doi:10.3109/01480545.2011.648327.
246. Owen, K., Beck, S.L., and Damment, S.J.P., 2010. The preclinical toxicology of salmeterol hydroxynaphthoate. Human Exp Toxicol 29(5):393-407.
247. Pabst, R., and Gehrke, I., 1990. Is the bronchus-associated lymphoid tissue (BALT) an integral structure of the lung in normal mammals, including humans? Am J Respir Cell Mol Biol 3:131-135.
248. Papiris, S.A., Triantafillidou, C., Kolilekas, L., Markoulaki, D., and Manali, E.D., 2010. Amiodarone review of pulmonary effects and toxicity. Drug Saf 33(7):539-558.
249. Patrikios, J., Martin, C.J., and Dent, J., 1986. Relationship of transient lower esophageal sphincter relaxation to postprandial gastroesophageal reflux and belching in dogs. Gastroenterology 90(3):545-551.
250. Patton, J.S., and Platz, R.M., 1992. Pulmonary delivery of peptides and proteins for systemic action. Adv Drug Del Rev 8:179-196.
251. Patton, J.S., and Byron, P.R., 2007. Inhaling medicines: delivering drugs to the body through the lungs. Nature 6:67-74.
252. Pauluhn, J., 2005. Inhaled cationic amphiphilic drug-induced pulmonary phospholipidosis in rats and dogs: time-course and dose-response of biomarkers of exposure and effect. Toxicology 207:59-72.
253. Percy, D.H., and Barthold, S.W., 2007. Pathology of Laboratory Rodents and Rabbits, 3rd edition, Blackwell Publishing, Ames, Iowa, USA.
254. Perese Serra, A., Parra, E.R., Eher, E., and Capelozzi, V.L., 2006. Nonhomogeneous immunostaining of hyaline membranes in different manifestations of diffuse alveolar damage. Clinics 61(6):497-502.
255. Piccotti, J.R., LaGattuta, M.S., Knight, S.A., Gonzales, A.J., and Bleavins, M.R., 2005. Induction of apoptosis by cationic amphiphilic drugs amiodarone and imipramine. Drug Chem Toxicol 28(1):117-133.
256. Pino, M.V., Valerio, M.G., Miller, G.K., Larson, J.L., Rosolia, D.L., Jayyosi, Z., Crouch, C.N., Trojanowski, J.Q., and Geiger, L.E., 1999. Toxicologic and carcinogenic effects of the type IV phosphodiesterase inhibitor RP 73401 on the nasal olfactory tissue in rats. Toxicol Pathol 27:383-394.
257. Plopper, C.G., and Harkema, J.R., 2005. The respiratory system and its uses in research. In: The Laboratory Primate. S. Wolfe-Coote, editor. Elsevier, London, pp. 503-526.
258. Presneill, J.J., Nakata, K., Inoue, Y., and Seymour, J.F., 2004. Pulmonary alveolar proteinosis. Clin Chest Med 25:593-613.
259. Price, P.A., Buckley, J.R., and Williamson, M.K., 2001. The amino bisphosphonate ibandronate prevents vitamin D toxicity and inhibits vitamin-D induced calcification of arteries, cartilage, lungs and kidneys in rats. J Nutr 131:2910-2915.
260. Rabinow, B.E., 2004. Nanosuspensions in drug delivery. Nat Rev 3:785-796.
261. Ramos-Barbón, D., Ludwig, M.S., and Martin, J.G., 2004. Airway remodelling. Lessons from animal models. Clin Rev Allergy Immunol 27:3-21.
262. Rasenack, N., Steckel, H., and Müller, B.W., 2003. Micronization of anti-inflammatory drugs for pulmonary delivery by a controlled crystallization process. J Pharm Sci 92:35-44.
263. Rawlins, E.L., Okubo, T., Xue, Y., Brass, D.M., Auten, R.L., Hasegawa, H., Wang, F., and Hogan, B.L.M. 2009. The role of Scgb1a1+ Clara cells in the long-term maintenance and repair of lung airway, but not alveolar, epithelium. Cell Stem Cell 4:525-534.
264. Reasor, M.J., and Kacew, S., 2001. Drug-induced phospholipidosis: are there functional consequences. Exp Biol Med 226(9):825-830.
265. Reid, L., Meyrick, B., Antony, V.B., Chang, L.Y., Crapo, J.D., and Reynolds, H.Y., 2005. The mysterious pulmonary brush cell: a cell in search of a function. Am J Respir Crit Care Med 172:136-139.
266. Renne, R.A., and Gideon, K.M., 2006. Types and patterns of response in the larynx following inhalation. Toxicol Pathol 34:281-285.
267. Renne, R.A., Gideon, K.M., Miller, R.A., Mellick, P.W., and Grumbein, S.L., 1992. Histologic methods and interspecies variations in the laryngeal histology of F344/N rats and B6C3F1 mice. Toxicol Pathol 20:44-51.
268. Renne, R.A., Sagartz, J.W., and Burger, G.T., 1993. Interspecies variations in the histology of toxicologically important areas in the larynges of CRL:CD rats and Syrian golden hamsters. Toxicol Pathol 21:542-546.
269. Renne, R., Brix, A., Harkema, J., Herbert, R., Kittel, B., Lewis, D., March, T., Nagano, K., Pino, M., Rittinghausen, S., Rosenbruch, M., Tellier, P., and Wohrmann, T., 2009. Proliferative and nonproliferative lesions of the rat and mouse respiratory tract. Toxicol Pathol 37:5S-73S.
270. Reynolds, S.D., Zemke, A.C., Giangreco, A., Brockway, B.L., Teisanu, R.M., Drake, J.A., Mariani, T., Di, P.Y.P., Taketo, M.M., and Stripp, B.R., 2008. Conditional stabilization of β-catenin expands the pool of lung stem cells. Stem Cells 26:1337-1346.
271. Rittinghausen, S., Dungworth, D.L., Ernst, H., and Mohr, U., 1992. Primary pulmonary tumors. In: Pathobiology of the Aging Rat, Volume 1. U. Mohr, D.L. Dungworth, C.C. Capen, W.W. Carlton, J.P. Sundberg, and J.M. Ward, editors. ILSI, Washington, pp. 161-172.
272. Rittinghausen, S., Dungworth, D.L., Ernst, H., and Mohr, U., 1996. Primary pulmonary tumors. In: Pathobiology of the Aging Mouse, Volume 1. U. Mohr, D.L. Dungworth, C.C. Capen, W.W. Carlton, J.P. Sundberg, and J.M. Ward, editors. ILSI, Washington, pp. 301-314.
273. Rittinghausen, S., and Kaspareit, J., 1998. Spontaneous cystic keratinizing epithelioma in the lung of a Sprague-Dawley rat. Toxicol Pathol 26:298-300.
274. Rooney, S.A., Young, S.L., and Mendelson, C.R., 1994. Molecular and cellular processing of lung surfactant. FASEB J 8:957-967.
275. Rossi, S.E., Erasmus, J.J., McAdams, H.P., Sporn, T.A., and Goodman, P.C., 2000. Pulmonary drug toxicity: radiologic and pathologic manifestations. RadioGraphics 20:1245-1259.
276. Roth, F.D., Quintar, A.A., Echevarría, E.M.U., Torres, A.I., Aoki, A., and Maldonado, C.A., 2007. Budesonide effects on Clara cell under normal and allergic inflammatory condition. Histochem Cell Biol 127:55-68.
277. Rygh, P., and Selvig, K.A., 1973. Erythrocyte crystallization in rat molar periodontium incident to tooth movement. Scand J Dent Res 81:62-73.
278. Sakagami, T., Beck, D., Uchida, K., Suzuki, T., Carey, B.C., Nakata, K., Keller, G., Wood, R.E., Wert, S.E., Ikegami, M., Whitsett, J.A., Luisetti, M., Davies, S., Krischer, J.P., Brody, A., Ryckman, F., and Trapnell, B.C., 2010. Patient-derived granulocyte/macrophage colony-stimulating factor autoantibodies reproduce pulmonary alveolar proteinosis in nonhuman primates. Am J Respir Crit Care Med 182:49-61.
279. Sakuma, T., Zhao, Y., Sugita, M., Sagawa, M., Toga, H., Ishibashi, T., Nishio, M., and Matthay, M.A., 2004. Malnutrition impairs alveolar fluid clearance in rat lungs. Am J Physiol Lung Cell Mol Physiol 286:L1268-L1274.
280. Sasaki, M., Namioka, Y., Ito, T., Izumiyama, N., Fukui, S., Watanabe, A., Kashima, M., Sano, M., Shioya, T., and Miura, M., 2001. Role of ICAM-1 in the aggregation and adhesion of human alveolar macrophages in response to TNF-α and INF-γ. Mediat Inflamm 10:309-313.
281. Sass, B., and Liebelt, A.G., 1985. Metastatic tumors, lung, mouse. In: Respiratory System. T.C. Jones, U. Mohr, and R.D. Hunt, editors. Springer-Verlag, Berlin, pp. 138-159.
282. Sato, S., and Kishikawa, T., 2001. Ultrastructural study of the alveolar lining and the bronchial mucus layer by block staining with oolong tea extract: the role of various surfactant materials. Med Electron Microsc 34:142-151.
283. Schemitsch, E.H., Turchin, D.C., Anderson, G.I., Byrick, R.J., Mullen, J.B., and Richards, R.R., 1998. Pulmonary and systemic fat embolization after medullary canal pressurization: a hemodynamic and histologic investigation in the dog. J Trauma 45(4):738-42.
284. Schlage, W.K., Bulles, H., Friedrichs, D., Kuhn, M., and Teredesai, A., 1998. Cytokeratin expression patterns in the rat respiratory tract as markers of epithelial differentiation in inhalation toxicology. I. Determination of normal cytokeratin expression patterns in nose, larynx, trachea, and lung. Toxicol Pathol 26:324-343.
285. Schleh, C., Mühlfeld, C., Pulskamp, K., Schmiedl, A., Nassimi, M., Lauenstein, H.D., Braun, A., Krug, N., Erpenbeck, V.J., and Hohlfeld, J.M., 2009. The effect of titanium dioxide nanoparticles on pulmonary surfactant function and ultrastructure. Respir Res 10:90.
286. Schmiedl, A., Hoymann, H.-G., Ochs, M., Menke, A., Fehrenbach, A., Krug, N., Tschernig, T., and Hohlfeld, J.M., 2003. Increase of inactive intra-alveolar surfactant subtypes in lungs and asthmatic Brown Norway rats. Virchows Arch 442:56-65.
287. Schneider, P., and Pappritz, G., 1976. Hairs causing pulmonary emboli. A rare complication in long-term intravenous studies in dogs. Vet Pathol 13(5):394-404.
288. Schraufnagel, D.E., 2010. Lung lymphatic anatomy and correlates. J Pathophys. 17:337-343.
289. Schreider, J.P., and Rabbe, O.G., 1981. Anatomy of the nasal-pharyngeal airway of experimental animals. Anat Rec 200:195-205.
290. Sells, D.M., Brix, A.E., Nyska, A., Jokinen, M.P., Orzech, D.P., and Walker, N.J., 2007. Respiratory tract lesions in noninhalation studies. Toxicol Pathol 35:170-177.
291. Sendo, T., Hirakawa, M., Fujie, K., Kataoka, Y., and Oishi, R., 1999. Contrast medium-induced pulmonary edema is aggravated by silicone contamination in rats. Radiology 212:97-102.
292. Seymour, J.F., and Presneill, J.J., 2002. Pulmonary alveolar proteinosis. Am J Respir Crit Care Med 166:215-235.
293. Shenberger, J.S., Shew, R.L., and Johnson, D.E., 1997. Hyperoxia-induced airway remodelling and pulmonary neuroendocrine cell hyperplasia in the weanling rat. Pediat Res 42(4):539-544.
294. Sheppard, M.N., and Thurlow, N.P., 1992. Distribution of the cytoskeletal protein β-tubulin in normal lung, cryptogenic fibrosing alveolitis and lung tumors. Histopathology 20:421-425.
295. Shinagawa, K., and Kojima, M., 2003. Mouse model of airway remodelling. Strain differences. Am J Respir Crit Care Med 168:959-967.
296. Sims, D.E., and Horne, M.M., 1997. Heterogeneity of the composition and thickness of tracheal mucus in rats. AJP Lung Physiol 273(5):L1036-L1041.
297. Singh, G., and Katyal, S.L., 2000. Clara cell proteins. Ann N Y Acad Sci 923:43-58.
298. Slesinski, R.S., and Turnbull, D., 2008. Chronic inhalation exposure of rats for up to 104 weeks to a non-carbon-based magnetite photocopying toner. Int J Toxicol 27:427-439.
299. Snipes, M.B., 1989. Long-term retention and clearance of particles inhaled by mammalian species. Crit Rev Toxicol 20:3 175-211.
300. Snipes, M.B., 1996. Current information on lung overload of nonrodent mammals: contrast with rats. Inhal Toxicol 8(suppl):91-109.
301. Snipes, M.B., McClellan, R.O., Mauderly, J.L., and Wolff, R.K., 1989. Retention patterns for inhaled particles in the lung: comparisons between laboratory animals and humans for chronic exposures. Health Phys 57:69-77.
302. Snyder, J.C., Reynolds, S.D., Hollingsworth, J.W., Li, Z., Kaminski, N., and Stripp, B.R., 2010. Clara cells attenuate the inflammatory response through regulation of macrophage behaviour. Am J Respir Cell Mol Biol 42(2):161-171.
303. Sorokin, S.P., and Brain, J.D., 1975. Pathways of clearance in mouse lungs exposed to iron oxide aerosols. Anat Rec 181:581-626.
304. Spencer, A.J., Wilson, S.A., Batchelor, J., Reid, A., Rees, J., and Harpur, E., 1997. Gadolinium chloride toxicity in the rat. Toxicol Pathol 25(3):245-255.
305. Spencer, A., Wilson, S., and Harpur, E., 1998. Gadolinium chloride toxicity in the mouse. Human Exp Toxicol 17:633-637.
306. St. Clair, M.G.B., and Morgan, K.T., 1992. Changes in the upper respiratory tract. In: Pathobiology of the Aging Rat, Volume 1. U. Mohr, D.L. Dungworth, and C.C. Capen, editors. ILSI Press, Washington, pp. 111-128.
307. Stout, R.D., Jiang, C., Matta, B., Tietzel, I., Watkins, S.K., and Suttles, J., 2005. Macrophages sequentially change their functional phenotype in response to changes in microenvironmental influences. J Immunol 175:342-349.
308. Strickland, D., Kees, U.R., and Holt, P.G., 1996a. Regulation of T-cell activation in the lung: isolated lung T-cells exhibit surface phenotypic characteristics of recent activation including down-modulated T-cell receptors, but are locked into the G0/G1 phase of cell cycle. Immunology 87:242-249.
309. Strickland, D., Kees, U.R., and Holt, P.G., 1996b. Regulation of T-cell activation in the lung: alveolar macrophages induce reversible T-cell energy in vitro associated with inhibition of interleukin-2 receptor signal transduction. Immunology 87:250-258.
310. Sturgess, J., and Reid, L., 1973. The effect of isoprenaline and pilocarpine on (a) bronchial mucus-secreting tissue and (b) pancreas, salivary glands, heart, thymus, liver and spleen. Br J Exp Pathol 54(4):388-403.
311. Takagi, M., Shiraiwa, K., Kusuoka, O., and Tamura, K., 2010. A case of olfactory neuroblastoma induced in a rat by N-nitrosobis(2-hydroxypropyl)amine. J Toxicol Pathol 23:111-114.
312. Takaro, T., Chapman, W.E., Burnette, R., and Cordell, S., 1990. Acute and subacute effects of injury on the canine alveolar septum. Chest 98:724-732.
313. Takeyama, K., Dabbagh, K., Lee, H.-M., Agusti, C., Lausier, J.A., Ueki, I.F., Grattan, K.M., and Nadel, J.A., 1999. Epidermal growth factor system regulates mucin production in airways. Proc Natl Acad Sci 96:3081-3086.
314. Takizawa, H., Suko, M., Shoji, S., Ohta, K., Horiuchi, T., Okudaira, H., Miyamoto, T., and Shiga, J., 1986. Granulomatous pneumonitis induced by bacille Calmette-Guérin in the mouse and its treatment with cyclosporin A. Am Rev Respir Dis 134(2):296-299.
315. Tang, K., Rossiter, H.B., Wagner, P.D., and Breen, E.C., 2004. Lung-targeted VEGF inactivation leads to an emphysema phenotype in mice. J Appl Physiol 97:1559-1566.
316. Tavana, H., Zamankhan, P., Christensen, P.J., Grotberg, J.B., and Takayama, S., 2011. Epithelium damage and protection during reopening of occluded airways in a physiological microfluidic pulmonary airway model. Biomed Microdevices 13(4):731-742.
317. Templin, M.V., Levin, A.A., Graham, M.J., Aberg, P.M., Axelsson, B.I., Butler, M., Geary, R.S., and Bennett, C.F., 2000. Pharmacokinetic and toxicity profile of a phosphorothioate oligonucleotide following inhalation delivery to lung in mice. Antisense Nucleic Acid Drug Dev 10:359-368.
318. Thomassen, M.J., Barna, B.P., Malur, A.G., Bonfield, T.L., Farver, C.F., Malur, A., Dalrymple, H., Kavuru, M.S., and Febbraio, M., 2007. ABCG1 is deficient in alveolar macrophages of GM-CSF knockout mice and patients with pulmonary alveolar proteinosis. J Lipid Res 48:2762-2768.
319. Thornton-Manning, J.R., and Dahl, A.R., 1997. Metabolic capacity of nasal tissue: interspecies comparisons of xenobiotic-metabolizing enzymes. Mutat Res/Fundam Molec Mech Mutagen 380:43-59.
320. Trapnell, B.C., and Whitsett, J.A., 2002. GM-CSF regulates pulmonary surfactant homeostasis and alveolar macrophage-mediated innate host defense. Annu Rev Physiol 64:775-802.
321. Tuazon, J.G., Modell, J.H., Hood, C.I., and Swenson, E.W., 1973. Pulmonary function after ventilation with fluorocarbon liquid (caroxin-D). Anesthesiology 3(2):134-140.
322. Ulich, T.R., Yi, E.S., Longmuir, K., Yin, S., Biltz, R., Morris, C.F., Housley, R.M., and Pierce, G.F., 1994. Keratinocyte growth factor is a growth factor for type II pneumocytes in vivo. J Clin Invest 93:1298-1306.
323. Ullmann, A.J., Krammes, E., Sommer, S., Buschmann, I., Jahn-Muehl, B., Cacciapuoti, A., and Schmitt, H.-J., 2007. Efficacy of posaconazole and amphotericin B in experimental invasive pulmonary aspergillosis in dexamethasone immunosuppressed rats. J Antimicrob Chemother 60:1080-1084.
324. Valberg, P.A., Wolff, R.K., and Mauderly, J.L., 1985. Redistribution of retained particles. Effect of hyperpnea. Am Rev Respir Dis 131:273-280.
325. Valensi, P., Gaudey, F., Parries, J., and Attali, J.R., 1993. Glucagon and noradrenaline reduce erythrocyte deformability. Metabolism 42(9):1169-1172.
326. Van Miert, E., Dumont, X., and Bernard, A., 2005. CC16 as a marker of lung epithelial hyperpermeability in an acute model of rats exposed to mainstream cigarette smoke. Toxicol Lett 159:115-123.
327. Villetti, G., Bergamaschi, M., Bassani, F., Bolzoni, P.T., Harrison, S., Gigli, P.M., Janni, A., Geppetti, P., Civelli, M., and Patacchini, R., 2006. Pharmacological assessment of the duration of action of glycopyrrolate vs tiotropium and ipratropium in guinea-pig and human airways. Br J Pharmacol 148:291-298.
328. Wagenvoort, C.A., Wagenvoort, N., and Dijk, H.J., 1974. Effect of fulvine on pulmonary arteries and veins of the rat. Thorax 29:522-529.
329. Wan, H., Kaestner, K.H., Ang, S.L., Ikegami, M., Finkelman, F.D., Stahlman, M.T., Fulkerson, P.C., Rothenberg, M.E., and Whitsett, J.A., 2004. Foxa2 regulates alveolarization and goblet cell hyperplasia. Development 131:953-964.
330. Ward, J.M., Uno, H., Kurata, Y., Weghorst, C.M., and Jang, J.-J., 1993. Cell proliferation not associated with carcinogenesis in rodents and humans. Environ Health Perspect 101:125-136.
331. Wardlaw, A.J., Guillen, C., and Morgan, A., 2005. Mechanisms of T cell migration to the lung. Clin Exp Allerg 35:4-7.
332. Watson, T.M., Reynolds, S.D., Mango, G.W., Boe, I.-M., Lund, J., and Stripp, B.R., 2001. Altered lung gene expression in CCSP-null mice suggests immunoregulatory roles for Clara cells. Am J Physiol Lung Cell Mol Physiol 281:L1523-L1530.
333. Weaver, J.L., Zhang, J., Knapton, A., Miller, T., Espandiari, P., Smith, R., Gu, Y.-Z., and Snyder, R.D., 2010. Early events in vascular injury in the rat induced by the phosphodiesterase IV inhibitor SCH 351591. Toxicol Pathol 38:738-744.
334. Weber, K., Germann, P.G., Iwata, H., Hardisty, J., Kaufmann, W., and Rosenbruch, M., 2009. Lesions in the larynx of Wistar RccHanTM: WIST rats. J Toxicol Pathol 22:229-246.
335. White, M.R., Crouch, E., van Eijk, M., Hartshorn, M., Pemberton, L., Tornoe, I., Holmskov, U., and Hartshorn, K.L., 2005a. Cooperative anti-influenza activities of respiratory innate immune proteins and neuraminidase inhibitor. Am J Physiol Lung Cell Molec Physiol 288:L831-L840.
336. White, M.R., Crouch, E., Vesona, J., Tacken, P.J., Batenburg, J.J., Leth-Larsen, R., Holmskov, U., and Hartshorn, K.L., 2005b. Respiratory innate immune proteins differentially modulate the neutrophil respiratory burst response to influenza A virus. Am J Physiol Lung Cell Molec Physiol 289:L606-L616.
337. Williams, M.C., 2003. Alveolar type I cells: molecular phenotype and development. Annu Rev Physiol 65:669-695.
338. Wilson, B.D., Clarkson, C.E., and Lippmann, M.L., 1993. Amiodarone causes decreased cell-mediated immune responses and inhibits the phospholipase C signalling pathway. Lung 170:137-148.
339. Wilson, D.V., and Walshaw, R., 2004. Postanesthetic esophageal dysfunction in 13 dogs. J Am Anim Hosp Assoc 40(6):455-460.
340. Wilson, D.W., and Segall, H.J., 1990. Changes in type II cell populations in monocrotaline pneumotoxicity. Am J Pathol 136(6):1293-1299.
341. Wilson, D.W., Segall, H.J., Pan, L.C., Lamé, M.W., Estep, J.E., and Morin, D., 1992. Mechanisms and pathology of monocrotaline pulmonary toxicity. Crit Rev Toxicol 22(5/6):307-325.
342. Wilson, D.W., and Dungworth, D.L., 2002. Tumors of the respiratory tract. In: Tumors in Domestic Animals. D.J. Meuten, editor. Blackwell, Ames, IA, pp. 365-399.
343. Wong, B.A., 2007. Inhalation exposure systems: design, methods and operation. Toxicol Pathol 35:3-14.
344. Wysolmerski, R., Lagunoff, D., and Dahms, T., 1984. Ethchlorvynol-induced pulmonary edema in rats. An ultrastructural study. Am J Pathol 115:447-457.
345. Yeates, D.B., Aspin, N., Levison, H., Jones, M.T., and Bryan, A.C., 1975. Mucociliary tracheal transport rates in man. J Appl Physiol 39(3):487-495.
346. Yerer, M.B., Aydoğan, S., Comu, F.M., Arslan, M., Güneş-Ekinci, I., Kurtipek, O., and Unal, Y., 2006. The red blood cell deformability alterations under desfluran anesthesia in rats. Clin Hemorheol Microcirc 35:213-216.
347. Young, S.L., and Silbajoris, R., 1986. Dexamethasone increases adult rat lung surfactant lipids. J Appl Physiol 60(5):1665-1672.
348. Zhang, J., Snyder, R.D., Herman, E.H., Knapton, A., Honchel, R., Miller, T., Espandiari, P., Goodsaid, F.M., Rosenblum, I.Y., Hanig, J.P., Sistare, F.D., and Weaver, J.L., 2008. Histopathology of vascular injury in Sprague-Dawley rats treated with phosphodiesterase IV inhibitor SCH 351591 or SCH 534385. Toxicol Pathol 36:827-839.
349. Zhao, C.-Z., Fang, X.-C., Wang, D., Tang, F.-D., and Wang, X.-D., 2010. Involvement of type II pneumocytes in the pathogenesis of chronic obstructive pulmonary disease. Respir Med 104:1391-1395.
350. Zhou, L., Geraci, G., Hess, S., Yang, L., Wang, J., and Argikar, U., 2011. Predicting phospholipidosis: a fluorescence non-cell based in vitro assay for the determination of drug-phospholipid complex formation in early drug discovery. Anal Chem 83:6980-6987. Downloaded from http://pubs.acs.org on August 19, 2011.